Edge Therapeutics Inc (EDGE):企業財務及び戦略的SWOT分析

◆英語タイトル:Edge Therapeutics Inc (EDGE) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥32,700見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥65,400見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥98,100見積依頼/購入/質問フォーム


Edge Therapeutics Inc (Edge Therapeutics) discovers, develops and commercializes a range of hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neurological conditions for which limited and no current therapies exist. Its lead pipeline product EG-1962, a proprietary formulation, which is used to treat aneurysmal subarachnoid hemorrhage (aSAH), is in Phase 3 clinical trials and EG-1964 is in preclinical stage and used to prevent recurrent chronic subdural hematoma. The company uses its proprietary, programmable, biodegradable polymer-based development platform named Precise to develop products for the treatment of acute neurological conditions. Edge Therapeutics is headquartered in Berkeley Heights, New Jersey, the US.

Edge Therapeutics Inc Key Recent Developments

Nov 01, 2016: Edge Therapeutics Reports Third Quarter Financial Results
Oct 17, 2016: Edge Therapeutics Appoints Chief Operating Officer
Aug 03, 2016: Edge Therapeutics Reports Second Quarter Financial Results and Recent Highlights
Aug 02, 2016: Edge Therapeutics Announces Closing of $20 Million Debt Facility with Hercules Capital
Jul 06, 2016: Edge Therapeutics Announces Appointment of Harry J. Sacks, M.D., FAAP, as Vice President, Clinical Development

This comprehensive SWOT profile of Edge Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Edge Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Edge Therapeutics Inc – Key Information
Edge Therapeutics Inc – Overview
Edge Therapeutics Inc – Key Employees
Edge Therapeutics Inc – Key Employee Biographies
Edge Therapeutics Inc – Key Operational Heads
Edge Therapeutics Inc – Major Products and Services
Edge Therapeutics Inc – History
Edge Therapeutics Inc – Company Statement
Edge Therapeutics Inc – Locations And Subsidiaries
Edge Therapeutics Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Edge Therapeutics Inc – Business Description
Edge Therapeutics Inc – Corporate Strategy
Edge Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Edge Therapeutics Inc – Strengths
Edge Therapeutics Inc – Weaknesses
Edge Therapeutics Inc – Opportunities
Edge Therapeutics Inc – Threats
Edge Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Edge Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Edge Therapeutics Inc, Key Information
Edge Therapeutics Inc, Key Ratios
Edge Therapeutics Inc, Share Data
Edge Therapeutics Inc, Major Products and Services
Edge Therapeutics Inc, History
Edge Therapeutics Inc, Key Employees
Edge Therapeutics Inc, Key Employee Biographies
Edge Therapeutics Inc, Key Operational Heads
Edge Therapeutics Inc, Other Locations
Edge Therapeutics Inc, Subsidiaries
Edge Therapeutics Inc, Key Manufacturing facilities
Edge Therapeutics Inc, Key Competitors
Edge Therapeutics Inc, SWOT Analysis
Edge Therapeutics Inc, Ratios based on current share price
Edge Therapeutics Inc, Annual Ratios
Edge Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Edge Therapeutics Inc, Performance Chart
Edge Therapeutics Inc, Ratio Charts


★リサーチレポート[ Edge Therapeutics Inc (EDGE):企業財務及び戦略的SWOT分析(Edge Therapeutics Inc (EDGE) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。